Certain forms of advertisement can only be used after IRB approval. Advertisements designed to position a company as an authority in a particular indication cannot be regulated by an IRB however.
When a research participant wants to leave a study, a research site has very few options. However, if the patient arrived at the research site because of a recruiter, it may be wise to ask the recruiter to speak to the patient.
Many people are interested in becoming a CRA (Clinical Research Associate). Organizations that offer such training are not common, but interested people should use caution when choosing a training program.
The most difficult part of obtaining studies is approaching sponsors. This video offers suggestions to help research sites stand out after identifying sponsors through clinicaltrials.gov.
While very few CRA’s (Clinical Research Associates) are difficult to deal with, it is possible to escalate major concerns to the sponsor or CRO (Contract Research Organization). However because of the current low study supply, replacing a CRA may not be a priority to the Sponsors.
When studies in a certain indication are low, trying to do studies in a different indication may become necessary. A PI (Principal Investigator) may then decide to contract a Sub-I (Sub Investigator) with more experience in the new indication.